Results 111 to 120 of about 41,151 (199)

Dopaminergic drugs modulate fear extinction-related processes in humans, but effects are mild. [PDF]

Brain Commun
Doubliez A, Köster K, Müntefering L, Nio E, Diekmann N, Thieme A, Albayrak B, Nicksirat SA, Erdlenbruch F, Batsikadze G, Ernst TM, Cheng S, Merz CJ, Timmann D.   +13 more
europepmc   +1 more source

Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome [PDF]

, 2000
Iris Reuter
openalex   +1 more source

Spinocerebellar ataxias masquerading as movement disorders: clinical and genetic characterization. [PDF]

Front Neurol
Wei S, Zhao Z, Li N, Guo X, Chen J, Hu J.   +5 more
europepmc   +1 more source

Altered Cortical Gyrification, Functional Connections, and Underlying Neurotransmitter Information in Patients with Parkinson's Disease with Levodopa-Induced Dyskinesia. [PDF]

Neurol Ther
Si Q, Gan C, Cao X, Shi J, Yu S, Sun H, Wang X, Wang X, Wang G, Yuan Y, Zhang K.   +10 more
europepmc   +1 more source

A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa [PDF]

, 2000
Olivier Rascol, David J. Brooks, Amos D. Korczyn, Peter Paul De Deyn, Carl E Clarke, Anthony E. Lang   +5 more
openalex   +1 more source

Pharmacotherapy in Early Parkinson's Disease: A Pragmatic Approach. [PDF]

Ann Indian Acad Neurol
Sachithanandan S, Vijayaraghavan A, Venugopal R, Puthenveedu DK, Krishnan S.   +4 more
europepmc   +1 more source

Psychotic complications of long-term levodopa treatment of Parkinson's disease

, 1991
A. Friedman, J. Sienkiewicz
openalex   +1 more source

Correction: Levodopa Intestinal Gel Infusion Therapies in Advanced Parkinson's Disease: A Swedish Study on Real-World Use and Costs. [PDF]

Neurol Ther
Odin P, Tærud C, Samuelsson J, Sabelström E, Lagerlund J, Freilich J, Stelmaszuk MN.   +6 more
europepmc   +1 more source

Effect of Levodopa and Carbidopa on Recovery of Visual Function in Patients With Nonarteritic Anterior Ischemic Optic Neuropathy of Longer Than Six Months?? Duration

, 1996
Lyn A. Sedwick
openalex   +1 more source

Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's disease [PDF]

, 2000
Robert A. Hauser, William C. Koller, Jean Hubble, Teresita Malapira, Karen Busenbark, C. Warren Olanow   +5 more
openalex   +1 more source